Vivos Therapeutics, Inc. Proceeds from Issuance of Unsecured Debt
Vivos Therapeutics, Inc. (VVOS) reported Proceeds from Issuance of Unsecured Debt of $1.30 million for the 0-month period ending 2020-05-08, per its 10-Q/A filed 2022-11-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfUnsecuredDebt · last filed 2022-11-25
- 2020-05-08: Proceeds from Issuance of Unsecured Debt 0 month $1.30M.
| Period end | Proceeds from Issuance of Unsecured Debt 0 month |
|---|---|
| 2020-05-08 | $1.30M 10-Q/A · filed 2022-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |